Avitas Wealth Management LLC acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,065 shares of the biopharmaceutical company’s stock, valued at approximately $204,000. A number of […]